Asia Deal Watch: Oxford Biomedica’s First Japanese Partnership Focuses On Rare Retinal Disorder

 
• By Ian Haydock, Brian Yang, and Joseph Haas
  
Flag of Great Britain and Japan - Illustration
Partnership with Santen is Oxford Biomedica's first deal with a Japanese interest • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business